Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
53.01
+1.21 (2.33%)
Oct 29, 2026, 2:02 PM EDT - Market open
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Eton Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $71.5. The average 1-year stock price forecast is 34.89% higher than the current stock price, while the lowest is $68 (+28.29%) and the highest is $78 (+47.16%).
Price Target: $71.5 (+34.89%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $60 → $68 | Buy | Reiterates | $60 → $68 | +28.29% | Oct 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $70 | Buy | Maintains | $70 | +32.06% | Oct 14, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $62 → $76 | Buy | Reiterates | $62 → $76 | +43.38% | Aug 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Reiterates $40 | Buy | Reiterates | $40 | -24.54% | Jun 26, 2026 |
Financial Forecast
Revenue This Year
149.71M
from 79.95M
Increased by 87.26%
Revenue Next Year
220.38M
from 149.71M
Increased by 47.21%
EPS This Year
1.40
from 0.32
Increased by 337.50%
EPS Next Year
2.55
from 1.40
Increased by 82.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.